NCT04381494 - Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

January 27, 2022

Study Completion Date

January 27, 2022

Conditions

Unresectable Stage III NSCLC

Interventions

DEVICE

Multiparametric Mobile Technology

Using a spirometer, an armband, and a tablet to collect data.

Trial Locations (18)

10029

Research Site, New York

30322

Research Site, Atlanta

32308

Research Site, Tallahassee

33486

Research Site, Boca Raton

33612

Research Site, Tampa

37916

Research Site, Knoxville

40241

Research Site, Louisville

44646

Research Site, Massillon

45267

Research Site, Cincinnati

48341

Research Site, Pontiac

66205

Research Site, Westwood

78229

Research Site, San Antonio

80113

Research Site, Englewood

90806

Research Site, Long Beach

92705

Research Site, Santa Ana

98405

Research Site, Tacoma

98503

Research Site, Lacey

06062

Research Site, Plainville